Hercules Technology Growth Capital is a specialized finance company that primarily focuses on providing debt and equity financing solutions to venture capital-backed companies in the technology, life sciences, and renewable energy sectors
By offering customized financing options, the company supports innovative businesses at various stages of growth, facilitating their development and expansion while managing risk through a strategic investment approach. Hercules aims to maximize returns for its shareholders by leveraging its expertise in the startup ecosystem and establishing strong relationships with emerging companies and their investors.
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year ended December 31, 2024. The earnings release can be accessed at Hercules’ Investor Relations website at https://investor.htgc.com/financial-information/financial-results.
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a new supplemental cash distribution of $0.28 per share, to be distributed equally over four quarters beginning with a $0.07 per share distribution for the fourth quarter of 2024.
There has been a massive shift from companies quickly going for Initial Public Offerings to staying private for much longer (or never going through an IPO).
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth quarter 2024 total cash distribution of $0.47 per share. The following shows the key dates of the fourth quarter 2024 distribution payment:
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2024 financial results conference call for Thursday, February 13, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.
There has been a massive shift from companies quickly going for IPOs to staying private for longer. The growth in the number of companies staying private is reflected in the growth of private credit – and Hercules Capital Inc. (HTGC) benefits.
Hercules Capital Inc. is engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries.
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has renewed and upsized its existing $225.0 million credit facility with Sumitomo Mitsui Banking Corporation (“SMBC”) with an upsized credit facility under which Synovus Bank, Customers Bank and Apple Bank, together with SMBC, have committed a total of $300.0 million in credit capacity subject to borrowing base, leverage and other restrictions. The renewed credit facility also includes an uncommitted accordion feature expandable up to $500.0 million. The renewed credit facility matures in November 2029, including a 12-month amortization period.
WATERTOWN, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQIRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it has obtained a $200 million non-dilutive term loan facility from Hercules Capital, Inc. NYSE:HTGCNYSEHTGC)
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended September 30, 2024. The earnings release can be accessed at Hercules’ Investor Relations website at https://investor.htgc.com/financial-information/financial-results.
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a third quarter 2024 total cash distribution of $0.48 per share. The following shows the key dates of the third quarter 2024 distribution payment:
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2024 financial results conference call for Wednesday, October 30, 2024, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Moody’s Investors Service, Inc. (“Moody’s”) has reaffirmed Hercules an investment grade credit and corporate rating of Baa3 with a revised outlook to positive, as well as its underlying analysis.
Hercules Capital, Inc. (NYSEHTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be participating at the following event for the financial community:
